The Disaster Response Network is ACTIVE in response to COVID-19 & the Northern Alberta floods Click here to access & for more information
Toll Free: 1-888-424-0297 | Local: 780-424-0294

Primer: Preparing for Cannabis Legalization: A Psychologists’ Evidence-based Guide

Date 2021-03-31
Time 00:00 - 00:01
Location
Map URL Click here for directions
Audience Public
Non-member Cost $50.00 CAD
Member Cost See your Price
Learning Objectives
  • Understand what to expect in their local communities when cannabis becomes legalized.
  • Summarize the evidence for the addictive properties of cannabis and the risk of developing a problem when using it.
  • Demonstrate a basic understanding of what treatments for cannabis use disorders are supported by research and their primary clinical components.
  • Understand the role of lower risk cannabis use guidelines in clinical practice.
  • Recognize risk for misusing medically prescribed cannabis and how to monitor for it.
Abstract

Cannabis is the most widely used illicit substance in the world. Given the pending legalization of cannabis in Canada, an overview of facts about cannabis, and guidelines for the management of cannabis use disorder in clinical practice are timely. This series of webinars will answer the following questions:

1) What is the truth and what are the myths about the addictive properties of cannabis, and its medicinal use?
2) What should you expect when cannabis becomes legalized in Alberta? 3) What are the most evidence-based treatments for cannabis use disorder and how do we best implement them in practice?
3) Is it possible for your clients to use cannabis in a controlled manner without becoming addicted?
4) How should you manage risk if your client is using prescribed medical cannabis? The content will consist of a review of the latest research evidence, as well as published evidence-based clinical guidelines.

Presenter

Dr. Igor Yakovenko

Dr. Yakovenko is an assistant professor and a clinical psychologist in the Department of Psychology & Neuroscience at Dalhousie University. He previously completed his clinical residency at Yale University and a postdoctoral fellowship at the University of Alberta. His research focuses on the associated features and determinants of substance use, disordered gambling, and co-morbidity of addiction and other psychiatric disorders. His recent work has been invested in developing evidence-based public health interventions for cannabis use disorder including the implementation of online platforms to increase access to substance abuse treatment. A major goal of his research is to account for real-world conditions of mental health treatment delivery, such as frequent co-morbidity, in order to generate clinical guidelines and recommendations for integrated care of addiction and mental health.